{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:50:27Z","timestamp":1762624227790,"version":"3.37.3"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU 07.902"],"award-info":[{"award-number":["TTU 07.902"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["TR-SFB 36 A10"],"award-info":[{"award-number":["TR-SFB 36 A10"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0223258","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T21:03:22Z","timestamp":1569877402000},"page":"e0223258","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy"],"prefix":"10.1371","volume":"14","author":[{"given":"Benjamin","family":"Faist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Schlott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Stemberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Dennehy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Krackhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareike","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6tz U.","family":"Grigoleit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schiemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Dick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk H.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0400-2743","authenticated-orcid":true,"given":"Michael","family":"Neuenhahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"key":"pone.0223258.ref001","article-title":"The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies","author":"JR Passweg","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"pone.0223258.ref002","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"EA Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"pone.0223258.ref003","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-med-120617-041210","article-title":"Expanding Therapeutic Opportunities for Hematopoietic Stem Cell Transplantation: T Cell Depletion as a Model for the Targeted Allograft.","volume":"70","author":"C Cho","year":"2019","journal-title":"Annu Rev Med"},{"key":"pone.0223258.ref004","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/ejh.13194","article-title":"Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: The AdVance study","volume":"102","author":"M Gonz\u00e1lez-Vicent","year":"2019","journal-title":"Eur J Haematol"},{"key":"pone.0223258.ref005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcv.2010.07.008","article-title":"Antiviral treatment for severe EBV infections in apparently immunocompetent patients","volume":"49","author":"PI Rafailidis","year":"2010","journal-title":"J Clin Virol"},{"key":"pone.0223258.ref006","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group","volume":"340","author":"D Lowance","year":"1999","journal-title":"N Engl J Med"},{"key":"pone.0223258.ref007","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJM199104113241501","article-title":"A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group","volume":"324","author":"GM Schmidt","year":"1991","journal-title":"N Engl J Med"},{"key":"pone.0223258.ref008","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199112053252303","article-title":"Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation","volume":"325","author":"JM Goodrich","year":"1991","journal-title":"N Engl J Med"},{"key":"pone.0223258.ref009","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1111\/ajt.15135","article-title":"Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection","volume":"18","author":"L Cherrier","year":"2018","journal-title":"Am J Transplant"},{"key":"pone.0223258.ref010","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood-2016-06-688432","article-title":"How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients","volume":"128","author":"F Chaer El","year":"2016","journal-title":"Blood"},{"key":"pone.0223258.ref011","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/13543784.2017.1274733","article-title":"Letermovir for the management of cytomegalovirus infection","volume":"26","author":"LJ Bowman","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"key":"pone.0223258.ref012","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation","volume":"377","author":"FM Marty","year":"2017","journal-title":"N Engl J Med"},{"key":"pone.0223258.ref013","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(11)70024-X","article-title":"Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial","volume":"11","author":"FM Marty","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"pone.0223258.ref014","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbmt.2018.09.038","article-title":"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.","volume":"25","author":"FM Marty","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"pone.0223258.ref015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity","volume":"101","author":"M Boeckh","year":"2003","journal-title":"Blood"},{"key":"pone.0223258.ref016","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"EA Walter","year":"1995","journal-title":"N Engl J Med"},{"key":"pone.0223258.ref017","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20040613","article-title":"Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers","volume":"202","author":"M Cobbold","year":"2005","journal-title":"J Exp Med"},{"key":"pone.0223258.ref018","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"T Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"pone.0223258.ref019","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/blood-2013-12-547349","article-title":"Lowest numbers of primary CD8(+) T cells can reconstitute protective immunity upon adoptive immunotherapy","volume":"124","author":"C Stemberger","year":"2014","journal-title":"Blood"},{"key":"pone.0223258.ref020","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"AM Leen","year":"2006","journal-title":"Nat Med"},{"key":"pone.0223258.ref021","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes","volume":"2","author":"HE Heslop","year":"1996","journal-title":"Nat Med"},{"key":"pone.0223258.ref022","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial","volume":"110","author":"T Haque","year":"2007","journal-title":"Blood"},{"key":"pone.0223258.ref023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation","volume":"345","author":"CM Rooney","year":"1995","journal-title":"Lancet"},{"key":"pone.0223258.ref024","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/ajt.13023","article-title":"Adoptive T cell immunotherapy for treatment of ganciclovir-resistant cytomegalovirus disease in a renal transplant recipient","volume":"15","author":"N Macesic","year":"2015","journal-title":"Am J Transplant"},{"key":"pone.0223258.ref025","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"A Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"key":"pone.0223258.ref026","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1537-2995.2010.02940.x","article-title":"Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation","volume":"51","author":"A Schmitt","year":"2011","journal-title":"Transfusion"},{"key":"pone.0223258.ref027","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nm0602-631","article-title":"Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer","volume":"8","author":"M Knabel","year":"2002","journal-title":"Nat Med"},{"key":"pone.0223258.ref028","doi-asserted-by":"crossref","first-page":"e61384","DOI":"10.1371\/journal.pone.0061384","article-title":"MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy","volume":"8","author":"G D\u00f6ssinger","year":"2013","journal-title":"PLoS ONE"},{"key":"pone.0223258.ref029","article-title":"Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after alloHSCT","author":"M Neuenhahn","year":"2017","journal-title":"Leukemia"},{"key":"pone.0223258.ref030","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jcyt.2014.05.023","article-title":"Clinical-scale isolation of \u201cminimally manipulated\u201d cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease","volume":"16","author":"M Odendahl","year":"2014","journal-title":"Cytotherapy"},{"key":"pone.0223258.ref031","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.smim.2016.02.001","article-title":"Role of memory T cell subsets for adoptive immunotherapy","volume":"28","author":"DH Busch","year":"2016","journal-title":"Semin Immunol"},{"key":"pone.0223258.ref032","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1172\/JCI32103","article-title":"Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates","volume":"118","author":"C Berger","year":"2008","journal-title":"J Clin Invest"},{"key":"pone.0223258.ref033","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.immuni.2014.05.018","article-title":"Serial transfer of single-cell-derived immunocompetence reveals stemness of CD8(+) central memory T cells","volume":"41","author":"P Graef","year":"2014","journal-title":"Immunity"},{"key":"pone.0223258.ref034","doi-asserted-by":"crossref","first-page":"282ra48","DOI":"10.1126\/scitranslmed.aaa3700","article-title":"Long-lasting stem cell-like memory CD8+ T cells with a na\u00efve-like profile upon yellow fever vaccination","volume":"7","author":"SA Fuertes Marraco","year":"2015","journal-title":"Sci Transl Med"},{"key":"pone.0223258.ref035","doi-asserted-by":"crossref","first-page":"317ra198","DOI":"10.1126\/scitranslmed.aac8265","article-title":"Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory","volume":"7","author":"G Oliveira","year":"2015","journal-title":"Sci Transl Med"},{"key":"pone.0223258.ref036","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1182\/blood-2009-12-260539","article-title":"Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells","volume":"115","author":"M Bleakley","year":"2010","journal-title":"Blood"},{"key":"pone.0223258.ref037","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbmt.2014.01.032","article-title":"Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Na\u00efve T Cells and Retain Functional Pathogen-Specific Memory T Cells.","volume":"20","author":"M Bleakley","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"pone.0223258.ref038","doi-asserted-by":"crossref","first-page":"e35798","DOI":"10.1371\/journal.pone.0035798","article-title":"Novel serial positive enrichment technology enables clinical multiparameter cell sorting","volume":"7","author":"C Stemberger","year":"2012","journal-title":"PLoS ONE"},{"key":"pone.0223258.ref039","doi-asserted-by":"crossref","first-page":"e0171035","DOI":"10.1371\/journal.pone.0171035","article-title":"Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs","volume":"12","author":"F Schlott","year":"2017","journal-title":"PLoS ONE"},{"key":"pone.0223258.ref040","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1182\/blood-2004-02-0646","article-title":"Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells","volume":"104","author":"AM Leen","year":"2004","journal-title":"Blood"},{"key":"pone.0223258.ref041","article-title":"Presentation of a Conserved Adenoviral Epitope on HLA-C*0702 Allows Evasion of Natural Killer but Not T Cell Responses","author":"A Keib","year":"2017","journal-title":"Viral Immunol"},{"key":"pone.0223258.ref042","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nprot.2012.143","article-title":"Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells","volume":"8","author":"E Lugli","year":"2012","journal-title":"Nat Protoc"},{"key":"pone.0223258.ref043","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1086\/587749","article-title":"Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study","volume":"46","author":"J Yao","year":"2008","journal-title":"Clin Infect Dis"},{"key":"pone.0223258.ref044","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ijc.11045","article-title":"Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702-associated epitope MAGE-A12:170\u2013178","volume":"105","author":"MP Bettinotti","year":"2003","journal-title":"Int J Cancer"},{"key":"pone.0223258.ref045","doi-asserted-by":"crossref","first-page":"e0193554","DOI":"10.1371\/journal.pone.0193554","article-title":"Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells.","volume":"13","author":"F Schlott","year":"2018","journal-title":"PLoS ONE"},{"key":"pone.0223258.ref046","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/cyto.a.20643","article-title":"Phenotype and function of human T lymphocyte subsets: consensus and issues.","volume":"73","author":"V Appay","year":"2008","journal-title":"Cytometry A"},{"key":"pone.0223258.ref047","doi-asserted-by":"crossref","first-page":"e1003383","DOI":"10.1371\/journal.ppat.1003383","article-title":"Presentation of an Immunodominant Immediate-Early CD8+ T Cell Epitope Resists Human Cytomegalovirus Immunoevasion.","volume":"9","author":"S Ameres","year":"2013","journal-title":"PLoS Pathog"},{"key":"pone.0223258.ref048","article-title":"The hallmarks of CMV-specific CD8 T-cell differentiation","author":"SPH van den Berg","year":"2019","journal-title":"Med Microbiol Immunol"},{"key":"pone.0223258.ref049","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3389\/fimmu.2019.01719","article-title":"T Cell Dysfunction in Cancer Immunity and Immunotherapy.","volume":"10","author":"A Xia","year":"2019","journal-title":"Front Immunol"},{"key":"pone.0223258.ref050","doi-asserted-by":"crossref","first-page":"e77925","DOI":"10.1371\/journal.pone.0077925","article-title":"Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donor","volume":"8","author":"CE Bunse","year":"2013","journal-title":"PLoS ONE"},{"key":"pone.0223258.ref051","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/bmt.2017.34","article-title":"Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.","volume":"52","author":"JR Passweg","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"pone.0223258.ref052","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2010-10-265603","article-title":"Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns","volume":"117","author":"V Gupta","year":"2011","journal-title":"Blood"},{"key":"pone.0223258.ref053","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"H D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"pone.0223258.ref054","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/sj.leu.2404334","article-title":"Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents","volume":"20","author":"AJ Barrett","year":"2006","journal-title":"Leukemia"},{"key":"pone.0223258.ref055","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/sj.leu.2404328","article-title":"Reduced-intensity conditioning for acute myeloid leukemia: is this strategy correct","volume":"20","author":"HM Lazarus","year":"2006","journal-title":"Leukemia"},{"key":"pone.0223258.ref056","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.blre.2017.07.002","article-title":"The who, how and why: Allogeneic transplant for acute myeloid leukemia in patients older than 60years","volume":"31","author":"SA Wall","year":"2017","journal-title":"Blood Rev"},{"key":"pone.0223258.ref057","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.22233","article-title":"Acute myeloid leukemia: epidemiology and etiology","volume":"107","author":"B Deschler","year":"2006","journal-title":"Cancer"},{"key":"pone.0223258.ref058","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1182\/blood-2012-01-397828","article-title":"Equal-opportunity treatment of EBV-PTLD","volume":"119","author":"HE Heslop","year":"2012","journal-title":"Blood"},{"key":"pone.0223258.ref059","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.4049\/jimmunol.0802212","article-title":"Central Memory CD8+ T Cells Induce Graft-versus-Host Disease and Mediate Graft-versus-Leukemia","volume":"182","author":"H Zheng","year":"2009","journal-title":"The Journal of Immunology"},{"key":"pone.0223258.ref060","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1182\/blood-2006-04-016410","article-title":"Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse","volume":"109","author":"BJ Chen","year":"2007","journal-title":"Blood"},{"key":"pone.0223258.ref061","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2003-08-2987","article-title":"Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease","volume":"103","author":"BJ Chen","year":"2004","journal-title":"Blood"},{"key":"pone.0223258.ref062","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI17601","article-title":"Memory CD4+ T cells do not induce graft-versus-host disease","volume":"112","author":"BE Anderson","year":"2003","journal-title":"J Clin Invest"},{"key":"pone.0223258.ref063","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4049\/jimmunol.1801003","article-title":"Measuring Antiviral Capacity of T Cell Responses to Adenovirus","volume":"202","author":"A Keib","year":"2019","journal-title":"The Journal of Immunology"},{"issue":"Suppl 2","key":"pone.0223258.ref064","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1038\/bmt.2015.95","article-title":"T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells","volume":"50","author":"RJ O'Reilly","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"pone.0223258.ref065","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41590-019-0478-y","article-title":"Tick-TOX, it's time for T cell exhaustion","volume":"20","author":"TH Mann","year":"2019","journal-title":"Nat Immunol"},{"key":"pone.0223258.ref066","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1097\/QAD.0b013e3282eee548","article-title":"PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status","volume":"21","author":"D Sauce","year":"2007","journal-title":"AIDS"},{"key":"pone.0223258.ref067","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.4049\/jimmunol.1001783","article-title":"Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults","volume":"186","author":"J Duraiswamy","year":"2011","journal-title":"The Journal of Immunology"},{"key":"pone.0223258.ref068","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion","volume":"571","author":"O Khan","year":"2019","journal-title":"Nature"},{"key":"pone.0223258.ref069","article-title":"Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts","author":"M Bleakley","year":"2015","journal-title":"J Clin Invest"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0223258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:17:35Z","timestamp":1588961855000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0223258"}},"subtitle":[],"editor":[{"given":"Michael","family":"Nevels","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,30]]},"references-count":69,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0223258","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,9,30]]}}}